Twitter
Advertisement
Home Tags Neulasta

Tag: Neulasta

The first biosimilar drug to Neulasta has been approved by the U.S. Food and Drug Administration. Fulphila (pegfilgrastim) is approved for patients with non-myeloid cancer who are receiving myelosuppressive chemotherapy and have symptoms of febrile neutropenia.

FDA OKs 1st Biosimilar to Prevent Chemo-Related Infections

HealthDay.com - 0
Fulphila, biosimilar to Neulasta, helps reduce risk of infection during cancer treatment

EVEN MORE NEWS

POPULAR CATEGORY

© 2023 eHealthcare Solutions, LLC
2093 Philadelphia Pike #8370, Claymont, DE 19703
Ph: (609) 882-8887 | Fx: (425) 671-7796